Podcasts about brahmer

Today's episode of Lung Cancer Considered is part of our special series on seminal trials in thoracic oncology, focusing on the phase I study of the PD-1 inhibitor nivolumab. Hosts Dr. Narjust Florez and Dr. Stephen Liu discuss that study with guest Dr. Julie Brahmer from Johns Hopkins University. This podcast features surprise guest interviews with several doctors who were mentored by Dr. Brahmer.

This bull collecting, Brahmer training, Aggie footballer, man of God is here to Empower U! Listen closely and carefully, there's lots to learn from this man!

The B.I.STANDER Podcast is a conversational podcast unique to Bainbridge Island and Seattle Washington, that covers the Arts, Society & Culture told through Human Interest stories. The intent is to introduce interesting people, ideas, and conversations. We are not perfect and that's OK! Thank you for your support! The B.I.Stander Podcast is a listener supported show, please consider subscribing.   BE A FRIEND OF PODCASTVILLE AND TELL A FRIEND  The BISTANDER Podcast! Today we welcome Molly Brahmer  Local Muralist and artist   Blue Canary Auto NOW ALSO in Bremerton! Sound Reprographics Intro Song "Fly on the Wall by LeRoy Bell and available at:  Tower Records! Additional sound effects by: https://www.zapsplat.com/ Support the Show on PATREON "Be a friend, tell a friend!"

The TE from Pierce decommits from Nebraska decommits to Iowa State, what does it meanAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Andrew Rogers and Damon Benning bring you breaking news on Ben Brahmer decommitting from Nebraska. Hail Varsity Radio is brought to you by www.GoCurrency.com Tune into Coffee & Cream from 7-9 am on 1480 AM each week day.You can stream live on http://espnlincoln.comYou can also stream live Twitter @HVarsityRadio, or via youtube at https://youtube.com/@HailVarsityMagYou can also download the IHeart Radio or Tune In apps and search for 1480 Lincoln.Follow them on Twitter:Andrew Rogers: @andrewrogersTVDamon Benning: @damonbenningA Hurrdat Media Production. Hurrdat Media is a digital media and commercial video production company based in Omaha, NE. Find more podcasts on the Hurrdat Media Network and learn more about our other services today on HurrdatMedia.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 6: Management of metastatic NSCLC in special populations — Dr Levy. CME information and select publications

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Part 2: A roundtable discussion featuring Borghaei, Brahmer, Garon and Govindan. Genomic profiling for patients with metastatic NSCLC; role of liquid biopsy (00:00) Therapeutic approach for patients with NSCLC with no targetable mutations (10:02) Case (Dr Deutsch): A woman in her late 60s with metastatic squamous cell carcinoma of the lung and a high PD-L1 tumor proportion score (TPS) of 60% initially treated with pembrolizumab monotherapy receives carboplatin/paclitaxel and maintenance pembrolizumab upon disease progression (21:32) Case (Dr Picton): A man in his mid-80s and previous smoker receives carboplatin/paclitaxel/pembrolizumab as first-line therapy for metastatic squamous cell carcinoma of the lung (27:35) Selection of second-line therapy for patients with metastatic nonsquamous NSCLC; benefits and risks with the addition of ramucirumab to docetaxel (32:17) Perspective on the use of bevacizumab or ramucirumab in combination with an immune checkpoint inhibitor and chemotherapy for metastatic NSCLC (37:03) Case (Dr Martins): A man in his early 70s and previous smoker with metastatic nonsquamous NSCLC develops diarrhea with bleeding after receiving first-line pembrolizumab (45:42) Screening and clinical care of patients with lung cancer during the COVID-19 pandemic (48:59) Case (Dr Picton): A woman in her early 50s with metastatic squamous NSCLC with a BRAF tumor mutation receives carboplatin/pemetrexed/pembrolizumab followed by maintenance pemetrexed/pembrolizumab and develops immune-related colitis (55:18) Management of metastatic NSCLC with targetable EGFR mutations (1:01:56) Case (Dr Deutsch): A woman in her late 40s and never smoker with metastatic adenocarcinoma of the lung with an EGFR tumor mutation develops a T790M mutation 2 years after treatment with erlotinib and bevacizumab on a clinical trial (1:11:18) CME information and select publications

Beskedet om 21 dagars nedstängning i Indien kom plötsligt. Vi hade inte en chans att komma ut och handla hem mat och annat viktigt, säger Saba Brahmer, som bor i Lucknow med sin familj.  I Coronadagböckerna följer vi människor som påverkas av pandemin, världen över. Margita Boström margita.bostom@sverigesradio.se

Birthe Brahmer-Lohss ist bekannt als die beste Expertin für den ganzheitlichen Säure-Basen-Haushalt. Sie trainiert seit fast 20 Jahren Frauen aus der ganzen Welt in der Regulation ihrer Säure-Basen-Balance. Sie hat mehrere Bücher dazu geschrieben und arbeitet online als Coach/Heilerin für Detox, liebevolle Selbstfürsorge und Herzheilung. Mehr über Birthe kannst Du hier erfahren: Birthes Internetseite: https://birthe-basischgesund.com Birthe auf Youtube: https://www.youtube.com/birthebrahmerlohss Birthe auf Facebook: https://www.facebook.com/birthebrahmerlohss/ Birthe auf Instagram: https://www.instagram.com/birthe_basischgesund/ –––––––––––––––––––––––––––––––––––––––––––––––––––––––– Mach jetzt den entscheidenden Schritt in ein glückliches und erfülltes Leben! Was wäre, wenn es nur eine Gelegenheit für ein Leben in Glück und Erfüllung gäbe? JETZT ist der richtige Zeitpunkt, Deinem Leben eine neue Richtung zu geben! Und hier ist das richtige Event genau für diesen ersten entscheidenden Schritt: Abenteuer: Leben5.0 - Aufbruch jetzt! Einen ganzer Tag. Ziele, Visionen & Veränderungs-Energie! Meld Dich jetzt zu einem meiner kommenden Events an und sei dabei! http://www.aufbruch-jetzt.com/ Herzlich willkommen zu Aufbruch jetzt! –––––––––––––––––––––––––––––––––––––––––––––––––––––––– Willst du wissen, was aus meiner Erfahrung der letzten 7 Jahre die fünf zentralen "Geheimnisse" sind, um Deinem Leben, egal aus welcher Lebenssituation heraus, eine neue Richtung zu geben? Dann lade ich Dich jetzt in den Leben5.0: Mitgliederbereich ein. Sicher Dir meinen Neuausrichtung: Leben5.0 - Video-Kurs mit samt einer Checkliste unter: www.christian-holzhausen.com Für frische Veränderungs- und Wachstums-Impulse werde Teil meiner Facebook-Community Neuausrichtung: Leben5.0 - Weil es um mein Leben geht. Es erwarten Dich dort unter anderem zum Tagesstart morgens um 06.30 Uhr folgende regelmäßige Live-Shows: Montags: Leben5.0: Impuls am Morgen Mittwochs: Leben5.0: Impuls am Morgen ~ FAQ ~ Freitags: Leben5.0: Ziele sichtbar machen Sei dabei! Folge direkt herunterladen

Birthe Brahmer-Lohss ist bekannt als die beste Expertin für den ganzheitlichen Säure-Basen-Haushalt. Sie trainiert seit fast 20 Jahren Frauen aus der ganzen Welt in der Regulation ihrer Säure-Basen-Balance. Sie hat mehrere Bücher dazu geschrieben und arbeitet online als Coach/Heilerin für Detox, liebevolle Selbstfürsorge und Herzheilung. Mehr über Birthe kannst Du hier erfahren: Birthes Internetseite: https://birthe-basischgesund.com Birthe auf Youtube: https://www.youtube.com/birthebrahmerlohss Birthe auf Facebook: https://www.facebook.com/birthebrahmerlohss/ Birthe auf Instagram: https://www.instagram.com/birthe_basischgesund/ –––––––––––––––––––––––––––––––––––––––––––––––––––––––– Mach jetzt den entscheidenden Schritt in ein glückliches und erfülltes Leben! Was wäre, wenn es nur eine Gelegenheit für ein Leben in Glück und Erfüllung gäbe? JETZT ist der richtige Zeitpunkt, Deinem Leben eine neue Richtung zu geben! Und hier ist das richtige Event genau für diesen ersten entscheidenden Schritt: Abenteuer: Leben5.0 - Aufbruch jetzt! Einen ganzer Tag. Ziele, Visionen & Veränderungs-Energie! Meld Dich jetzt zu einem meiner kommenden Events an und sei dabei! http://www.aufbruch-jetzt.com/ Herzlich willkommen zu Aufbruch jetzt! –––––––––––––––––––––––––––––––––––––––––––––––––––––––– Willst du wissen, was aus meiner Erfahrung der letzten 7 Jahre die fünf zentralen "Geheimnisse" sind, um Deinem Leben, egal aus welcher Lebenssituation heraus, eine neue Richtung zu geben? Dann lade ich Dich jetzt in den Leben5.0: Mitgliederbereich ein. Sicher Dir meinen Neuausrichtung: Leben5.0 - Video-Kurs mit samt einer Checkliste unter: www.christian-holzhausen.com Für frische Veränderungs- und Wachstums-Impulse werde Teil meiner Facebook-Community Neuausrichtung: Leben5.0 - Weil es um mein Leben geht. Es erwarten Dich dort unter anderem zum Tagesstart morgens um 06.30 Uhr folgende regelmäßige Live-Shows: Montags: Leben5.0: Impuls am Morgen Mittwochs: Leben5.0: Impuls am Morgen ~ FAQ ~ Freitags: Leben5.0: Ziele sichtbar machen Sei dabei! Folge direkt herunterladen

Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.

News Talk 94.1 — Miranda saw a need in Cookeville and decided to fill that need.  After years of working in the Nashville salon scene, Miranda decided to open Cookeville BlowDry & Co. right in the heart of the town! Here how it has been going for her and her plans for the future on this week’s Powered By Her.

Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.

Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.

Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.

Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.

Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.

Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.

The Current Application of and New Directions in Cancer Immunotherapy. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

The Current Application of and New Directions in Cancer Immunotherapy. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

The Current Application of and New Directions in Cancer Immunotherapy. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

The Current Application of and New Directions in Cancer Immunotherapy. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

The Current Application of and New Directions in Cancer Immunotherapy. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

The Current Application of and New Directions in Cancer Immunotherapy. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

Dr. Jack West, Dr. Julie Brahmer, and Dr. Ben Creelan discuss the excitement the medical community is feeling about immunotherapy for the treatment of lung cancer. February 2014

Dr. Jack West, Dr. Julie Brahmer, and Dr. Ben Creelan discuss the excitement the medical community is feeling about immunotherapy for the treatment of lung cancer. February 2014

Dr. Jack West, Dr. Julie Brahmer, and Dr. Ben Creelan discuss the excitement the medical community is feeling about immunotherapy for the treatment of lung cancer. February 2014

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Julie R Brahmer, MD conducted by Neil Love, MD. Produced by Research To Practice.

Drs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immune-based treatments for lung cancer.

Drs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immune-based treatments for lung cancer.

Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.

Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.

Case discussion with Dr. Julie Brahmer of Johns Hopkins University and Dr. Gregory Riely of Memorial Sloan Kettering, on a case of a woman with poorly differentiated NSCLC, responding well to fist line chemotherapy.

Case discussion with Dr. Julie Brahmer of Johns Hopkins University and Dr. Gregory Riely of Memorial Sloan Kettering, on a case of a woman with poorly differentiated NSCLC, responding well to fist line chemotherapy.

LungCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.